🇺🇸 FDA
Pipeline program

CEFTRIAXONE, AMOXICILLIN, AZITHROMYCIN

APHP230841

Phase 3 small_molecule active

Quick answer

CEFTRIAXONE, AMOXICILLIN, AZITHROMYCIN for Population of study participants Pregnant women with PPROM at 22 to 33 weeks’ gestation is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Population of study participants Pregnant women with PPROM at 22 to 33 weeks’ gestation
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials